Trial intelligence / Profile preview

Clevudine vs Clevudine + Vaccine in Chronic Hepatitis B

NCT00501124Phase 4Completed

Sponsor
Bukwang Pharmaceutical
Start
May 2007
Primary completion
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of clevudine in hepatitis B (HBV), sponsored by Bukwang Pharmaceutical. Started May 2007; status: completed.

02

Drugs

clevudine
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT00501124.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00501124.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call